View Press Releases
CD Genomics Updated Its Technology Platforms
NEW YORK, NY - Oct 14, 2014 - Recently, CD Genomics updated its technology platforms. Now it can offer its expertise in SNP and human microsatellite genotyping on a wide range of platforms for sequencing services, for instance, ABI 3730xl high throughput genetic analyzer, Roche 454 GS-FLX+ System, Illumina Hiseq 2000/2500, Miseq System, Ion Torrent PGM&Proton and PACBIO RS II. As a result, every customer will be given a customized platform to meet their specific scientific needs, resulting in high efficiency, high rate of success, and high profitability.
Additionally, CD Genomics offers a scaleable solution from genome wide association studies on tens of thousands of samples to single SNP interrogations of several hundred individuals. It also can synthesize the selected aptamer according to clients requirements.
About CD Genomics
Established in the year of 2004, CD Genomics has always been aiming at providing the research community with high quality manual DNA sequencing services. With its updated technology platform, CD Genomics now offer a range of services from Sequencing, Microarray, Custom Libraries, Bioinformatics, Genotyping to Aptamers, committed to offer the most reliable and accurate services to pharmaceutical and biotech companies, as well as academia and government agencies both at home and abroad. For more detailed information, please visit www.cd-genomics.com.
Contact
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel:1-631-626-9181
Fax: 1-631-614-7828
Email: info@cd-genomics.com